Chongqing Pharscin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002907.SZ

Chongqing Pharscin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -4.26 M

Chongqing Pharscin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities is USD -4.26 M for the year ending December 31, 2023, a 9.16% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -4.69 M, a -16.08% change year over year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -4.04 M, a -332.91% change year over year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD -932.76 K, a -102.63% change year over year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 35.52 M, a 36,123.76% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
SV Wall Street
Shenzhen Stock Exchange: 002907.SZ

Chongqing Pharscin Pharmaceutical Co., Ltd.

CEO Ms. Xiaoying Liu
IPO Date Oct. 20, 2017
Location China
Headquarters No. 89, Middle Sec of Huangshan Ave
Employees 1,411
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies
Description

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, hard capsules, soft capsules, powder injections, freeze-dried powder injections, small volume injections, and API synthesis. It provides its products in the areas of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.

StockViz Staff

February 3, 2025

Any question? Send us an email